FDA Inspection 1155479 — Magna Pharmaceuticals Inc

Magna Pharmaceuticals Inc — FEI 3007457368

The FDA completed an inspection of Magna Pharmaceuticals Inc on Oct 29, 2021 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 29, 2021
Fiscal Year
2022
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Louisville, KY (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.